San Diego, CA, United States of America

Sharon Lea Aukerman

This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sharon Lea Aukerman. Retrieved from https://idiyas.com/inventor/sharon-lea-aukerman-3spnh3ro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Sharon Lea Aukerman

Introduction: Sharon Lea Aukerman, based in San Diego, California, is a notable inventor, recognized for her contributions to medical research and treatment methodologies. With one patent to her name, she has made significant strides in the field of diabetes management.

Latest Patents: Sharon holds a patent for a "Method of treating diabetes mellitus using KGF," showcasing her innovative approach to addressing this prevalent health issue. Her patent reflects a commitment to improving patients' quality of life through scientific advancements.

Career Highlights: Currently, Sharon is employed at Amgen Inc., a leading biotechnology company known for its focus on innovative therapies. Her work at Amgen, coupled with her expertise in diabetes treatment, positions her as a key figure in the biotechnology arena.

Collaborations: Throughout her career, Sharon has collaborated with esteemed professionals in her field, including her coworker Glenn Francis Pierce. Their joint efforts further emphasize the importance of teamwork in driving innovation and transforming medical practices.

Conclusion: Sharon Lea Aukerman exemplifies the spirit of innovation in the medical field through her patent and collaborative efforts. As she continues her work at Amgen Inc., her contributions are likely to inspire further advancements in diabetes treatment and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…